H.R. 354 · 108th Congress
North American Prescription Price Equity Act of 2003
- Stage
- In committee
- Sponsor
- Jimmy Duncan
- Introduced
- 2003-01-27
- Latest action
- 2003-01-27 · Introduced in House
Summary
North American Prescription Price Equity Act of 2003 - Amends the Internal Revenue Code to allow drug manufacturers a limited tax credit if they certify that the wholesale price of a drug in the United States market is not greater than its wholesale price in the Canadian or Mexican market.